Is mesenchymal stem cell therapy suitable for reducing insulin resistance ın fructose induced metabolic syndrome rat model


BEYHAN ÖZDAŞ Ş., AKIN D., DEMİRCAN G., YAPIŞLAR H., KETENCİ S., KOLDEMİR GÜNDÜZ M., ...Daha Fazla

1st Pharmacogenomics İstanbul Summit: Increasing the Safety and Effectivness of Personalized therapy for Metabolic Disorders, Türkiye, 27 - 28 Kasım 2015

  • Basıldığı Ülke: Türkiye